Renal Cell Cancer, Recurrent Terminated Phase Trials for Sunitinib (DB01268)

Also known as: Recurrent Renal Cell Cancer

IndicationStatusPhase
DBCOND0082537 (Renal Cell Cancer, Recurrent)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01740154Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney CancerSupportive Care